Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway

Parkinson’s disease (PD) is a common neurodegenerative disease with global health and economic impact. 1-methyl-4-phenylpyridinium (MPP+)-induced mitochondrial dysfunction and oxidative stress are reported to participate in the pathological mechanism of PD. Ramelteon is a novel oral hypnotic agent t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chuo, Zhang, Yusheng, Liu, Rongrong, Mai, Yuzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806746/
https://www.ncbi.nlm.nih.gov/pubmed/34346829
http://dx.doi.org/10.1080/21655979.2021.1960767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806746/
https://www.ncbi.nlm.nih.gov/pubmed/34346829
http://dx.doi.org/10.1080/21655979.2021.1960767

Ejemplares similares